Effects of Quercetin on Cardiometabolic Outcomes

Sex: All

Ages: 18 Years – 65 Years

Healthy volunteers: Yes

Phase: NA

Enrollment: 40

Sponsor: University of Central Lancashire

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Quercetin may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Eligibility Criteria

Inclusion Criteria: * Healthy * Between 18 \& 65 years * BMI \< 30 * Able to give informed consent Exclusion Criteria: * Pregnancy * Diabetes or any other metabolic/ uncontrolled hypertensive conditions * Food allergies to quercetin * Habitual consumption of quercetin * Not regularly taking medication or antioxidant supplements

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06230861). StuddyBuddy aggregates publicly available trial information.